Women’s health leaders press for female subjects to be included in basic research studies
SWHR supports the National Institute of Health’s (NIH) move to include sex as a biological variable in future research.
SWHR held its second interdisciplinary roundtable on understanding sex and gender differences in Alzheimer’s disease May 28-29, 2015 at the Hyatt Regency Crystal City in Arlington, Va.
The Food and Drug Administration (FDA) Advisory Committee has made history for women by recommending approval of Sprout Pharmaceuticals’ twice-rejected female libido drug Flibanserin.
SWHR teamed with HealthyWomen, the National Association of Nurse Practitioners in Women’s Health, and the Coalition of Labor Union Women in partnership with CardioDx on a new patient advocacy campaign, Spread the Word, to empower women to be proactive in discussing their heart health.
United States Representatives Jim Cooper (D-TN) and Cynthia Lummis (R-WY) introduced the “Research for All Act of 2015” in Congress.
The United States Preventative Services Taskforce (USPSTF) released a new set of mammography guidelines, the first since the taskforce’s controversial 2009 update.
SWHR congratulates former Chair of the Board of Directors, Nanette K. Wenger, MD. Wenger for receiving the inaugural Bernadine Healy Leadership in Women’s Cardiovascular Disease Award at the recent 64th Annual American College of Cardiology Scientific Session in San Diego, California.
SWHR commends Barbra Streisand for her commentary in The Washington Post, titled, “The Battle For Women’s Hearts – And Lives,” and for bringing into the public eye the work that SWHR has been doing for 25 years.